Springfield C, Pinkham A, Harvey P, Moore R, Ackerman R, Depp C
Behav Sci (Basel). 2024; 14(3).
PMID: 38540495
PMC: 10968649.
DOI: 10.3390/bs14030192.
Liu H, Gao W, Cao W, Meng Q, Xu L, Kuang L
BMC Psychiatry. 2023; 23(1):515.
PMID: 37464363
PMC: 10354910.
DOI: 10.1186/s12888-023-05012-3.
Jauk E, Kanske P
J Intell. 2019; 7(2).
PMID: 31162389
PMC: 6631125.
DOI: 10.3390/jintelligence7020010.
Lee S, Wang T, Chen S, Chang Y, Chen P, Huang S
Alcohol Clin Exp Res. 2018; 42(6):1044-1050.
PMID: 29656414
PMC: 6473794.
DOI: 10.1111/acer.13640.
Chang H, Chen P, Cheng Y, Wang T, Yang Y, Lu R
Int J Neuropsychopharmacol. 2018; 21(4):319-324.
PMID: 29618013
PMC: 5888470.
DOI: 10.1093/ijnp/pyx093.
A longitudinal study of the association between the GNB3 C825T polymorphism and metabolic disturbance in bipolar II patients treated with valproate.
Chen P, Chang H, Huang C, Lee C, Lee S, Chen S
Pharmacogenomics J. 2016; 17(2):155-161.
PMID: 26856249
DOI: 10.1038/tpj.2015.96.
Psychotherapy for Bipolar II Disorder: The Role of Interpersonal and Social Rhythm Therapy.
Swartz H, Levenson J, Frank E
Prof Psychol Res Pr. 2015; 43(2):145-153.
PMID: 26612968
PMC: 4657867.
DOI: 10.1037/a0027671.
Factors influencing self-assessment of cognition and functioning in bipolar disorder: a preliminary study.
Harvey P, Paschall G, Depp C
Cogn Neuropsychiatry. 2015; 20(4):361-71.
PMID: 26057868
PMC: 4477193.
DOI: 10.1080/13546805.2015.1044510.
Interaction of DRD2TaqI, COMT, and ALDH2 genes associated with bipolar II disorder comorbid with anxiety disorders in Han Chinese in Taiwan.
Hu M, Lee S, Wang T, Chang Y, Chen S, Chen S
Metab Brain Dis. 2014; 30(3):755-65.
PMID: 25430946
DOI: 10.1007/s11011-014-9637-x.
Add-on memantine to valproate treatment increased HDL-C in bipolar II disorder.
Lee S, Chen S, Chang Y, Chen P, Huang S, Tzeng N
J Psychiatr Res. 2013; 47(10):1343-8.
PMID: 23870798
PMC: 4786167.
DOI: 10.1016/j.jpsychires.2013.06.017.
Inflammation's Association with Metabolic Profiles before and after a Twelve-Week Clinical Trial in Drug-Naïve Patients with Bipolar II Disorder.
Lee S, Chen S, Chang Y, Chen P, Huang S, Tzeng N
PLoS One. 2013; 8(6):e66847.
PMID: 23826157
PMC: 3695222.
DOI: 10.1371/journal.pone.0066847.
Systematic review reveals heterogeneity in the use of the Scale to Assess Unawareness of Mental Disorder (SUMD).
Dumas R, Baumstarck K, Michel P, Lancon C, Auquier P, Boyer L
Curr Psychiatry Rep. 2013; 15(6):361.
PMID: 23636985
DOI: 10.1007/s11920-013-0361-8.
Correlations between awareness of illness (insight) and history of addiction in heroin-addicted patients.
Maremmani A, Rovai L, Rugani F, Pacini M, Lamanna F, Bacciardi S
Front Psychiatry. 2012; 3:61.
PMID: 22787450
PMC: 3391664.
DOI: 10.3389/fpsyt.2012.00061.
Insight in bipolar disorder.
Latalova K
Psychiatr Q. 2011; 83(3):293-310.
PMID: 22101737
DOI: 10.1007/s11126-011-9200-4.
Comorbid anxiety and substance use disorders associated with a lower use of mood stabilisers in patients with rapid cycling bipolar disorder: a descriptive analysis of the cross-sectional data of 566 patients.
Gao K, Kemp D, Conroy C, Ganocy S, Findling R, Calabrese J
Int J Clin Pract. 2010; 64(3):336-44.
PMID: 20456174
PMC: 3457056.
DOI: 10.1111/j.1742-1241.2009.02284.x.
Relationship between insight, cognitive function, social function and symptomatology in schizophrenia: the West London first episode study.
Mutsatsa S, Joyce E, Hutton S, Barnes T
Eur Arch Psychiatry Clin Neurosci. 2006; 256(6):356-63.
PMID: 16902732
DOI: 10.1007/s00406-006-0645-7.
Disorders of awareness in neuropsychiatric syndromes: an update.
Flashman L
Curr Psychiatry Rep. 2002; 4(5):346-53.
PMID: 12230963
DOI: 10.1007/s11920-002-0082-x.